Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

[1]  R. Hoppe,et al.  Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Deeg,et al.  High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Goris,et al.  90Y-ANTI-CD20 MONOCLONAL ANTIBODY THERAPY (IDEC-Y2B8) FOR RECURRENT B CELL LYMPHOMA , 1994 .

[4]  S. Tucker,et al.  ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Norton,et al.  Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  F. Cabanillas,et al.  MINE-ESHAP salvage therapy for recurrent and refractory lymphomas. , 1994, Seminars in hematology.

[7]  S. Horning,et al.  Treatment approaches to the low-grade lymphomas. , 1994, Blood.

[8]  I. Bernstein,et al.  Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. , 1993, The New England journal of medicine.

[9]  J. Armitage.  Bone marrow transplantation for indolent lymphomas. , 1993, Seminars in oncology.

[10]  M. Czuczman,et al.  Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Freedman,et al.  Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Kaminski,et al.  Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. , 1993, The New England journal of medicine.

[13]  F. Appelbaum,et al.  Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor , 1993 .

[14]  G. McDonald,et al.  Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.

[15]  T. Waldmann,et al.  The Multichain Interleukin-2 Receptor: A Target for Immunotherapy , 1988, Annals of Internal Medicine.

[16]  S. Order,et al.  Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Goldenberg,et al.  Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Sanders.  Endocrine problems in children after bone marrow tranplant for hematologic malignancies , 1991 .

[19]  R. Hill,et al.  Internal radiation dosimetry for clinical testing of radiolabeled monoclonal antibodies , 1990 .

[20]  I. Bernstein,et al.  Imaging and treatment of B-cell lymphoma. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  D. Scheinberg,et al.  A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  B. Yeap,et al.  Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Fisher Ri,et al.  Treatment options for recurrent lymphomas. , 1990 .

[24]  K. Sullivan,et al.  Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  G. Denardo,et al.  Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1. , 1990, Cancer research.

[26]  M Tubiana,et al.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Eary,et al.  Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Eary,et al.  Preliminary validation of the opposing view method for quantitative gamma camera imaging. , 1989, Medical physics.

[29]  A. M. Zimmer,et al.  Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[30]  F. Appelbaum,et al.  Regimen-related toxicity in patients undergoing bone marrow transplantation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  D. Schwartz,et al.  Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. , 1988, The American review of respiratory disease.

[32]  H. Deeg,et al.  Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  S. Horning.  Durable remissions in stage III follicular lymphoma: interpret with caution. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  S. Leibel,et al.  Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.